Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance

Bryan, Garnier & Co combines with Nordic growth investment bank Beringer Finance, further strengthening the firm’s leadership in the European investment banking landscape.

  • The group expands its European footprint with the addition of offices in Stockholm, Oslo and Reykjavik. Bryan, Garnier & Co will also add the current Beringer Finance Palo Alto office to its existing US presence in NYC.
  • CEO Adalsteinn Johannsson will join Bryan, Garnier & Co as Partner focused on International M&A, with Beringer’s Tor Berthelius as Partner to lead the Nordic operations.
  • The combination reinforces the group with 31 professionals focused on Technology, IT Services and Fintech.
  • Beringer has conducted more than 140 M&A, ECM and Private Placements transactions in the past 10 years alone, and benefits from a leading position in the Nordic markets.
  • The combination provides a strong foothold for the firm to expand its leading European Life-Sciences practice in the Nordics.

[London, Paris, Munich] — Wednesday 17th April, 2019. Today, Bryan, Garnier & Co announced the acquisition of Beringer Finance and the expansion of its partnership. Beringer Finance is a premier, Nordic-focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto. Throughout the past 10 years, Beringer Finance has advised on over 140 transactions, building a strong track record in the TMT, IT Services, and Fintech markets. The closing is subject to pending regulatory approvals and other customary closing conditions.

Olivier Garnier, Co-founder and Managing Partner of Bryan, Garnier & Co comments: “Bryan, Garnier & Co is an independent partnership that combines highly experienced, entrepreneur-minded investment banking professionals with the services and expertise of a top-tier investment bank. The culture of excellence at Beringer Finance and our shared ambition to expand will be a strong driver to accelerate Bryan, Garnier & Co’s development in the region, across our business lines and industry sectors. We are delighted to welcome Adalsteinn Johannsson and his team to lead this effort”.

“The Nordics is one of the main European Technology and Life Sciences hubs where we have longstanding client relationships” comments Greg Revenu, Managing Partner of Bryan, Garnier & Co. “This combination not only creates an exciting opportunity for the firm and its teams, but also a unique capacity to support the growth of our clients: it propels our Technology coverage to the next level, while opening a new challenge to our leading European healthcare franchise.”

“We are excited to be joining forces with Bryan, Garnier & Co” explains Adalsteinn Johannsson, CEO at Beringer Finance. “Its full-service capacities combining investment banking and capital markets services provides us with the scale and resources to accelerate our growth. Bryan, Garnier & Co’s entrepreneurial DNA is a perfect match for the strong culture and unique approach we have built at Beringer. We very much look forward writing this journey together with this outstanding team.”

Beringer Finance will be operating under the Bryan, Garnier & Co brand with CEO Adalsteinn Johannsson joining Bryan, Garnier & Co as a partner focused on International M&A, with Beringer’s Tor Berthelius as a partner to lead the Nordic operations. Beringer’s 27 technology-focused bankers will be fully integrated with Bryan, Garnier & Co’s existing investment banking professionals, across its London, Paris, Munich, Stockholm, Oslo, Reykjavik, New York and Palo Alto offices. With a European technology group of more than 80 professionals, Bryan, Garnier & Co will benefit from an unmatched position in the European technology investment banking landscape.

RECENT ACHIEVEMENTS

Over the past 24 months, Bryan, Garnier & Co and Beringer Finance have led more than 85 transactions, including backing three of the most disruptive unicorns of 2018:

  • 47 international public and private M&A deals representing an aggregate value of approximately $2.4 billion, many of which involved tier one private equity investors and publicly-listed trade buyers. Recent deals include the sale of Sword Apak to Sopra Banking Software, the sale of Symetis to Boston Scientific for $435m, the sale of Dimelo to RingCentral, the sale of Prima Solutions to the Carlyle Group, the 30% sale of Advania to VIA equity and PFA, and the sale of Universum to Axel Springer company StepStone.
  • 25 growth capital private placements and PIPEs representing an aggregated amount raised of some $550 million, for companies such as blockchain unicorn Bitfury ($80m), biotech unicorn Moderna ($80m), Tado° ($50m), Highlife ($37m), Devialet ($210m), and BraBank ($35m).
  • 15 IPOs and public offerings on Nasdaq, NYSE, Euronext, and other major exchanges for an aggregated amount of more than $1.4 billion, including four deals led or co-led on Nasdaq or NYSE. Recent transactions include: representation of cannabis unicorn Canopy Growth ($450m, TMX, NYSE), Medartis ($138m, Swiss Exchange), Materialise ($52m, Nasdaq), Medigene ($56m, Deutsche Börse Group), Celyad ($53m, Nasdaq, Euronext) and Genfit ($155.4m, Nasdaq).

About Beringer Finance

Beringer Finance is a technology focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto. Tracing its roots back over 100 years, Beringer is continuously driven by the ambition to help companies and entrepreneurs strategically develop and grow their businesses while realizing their dreams and their aspirations.
Their expertise and market leadership have seen them advise top-tier clients on over 140 transactions in the past 10 years. Despite calling the Nordics its home, Beringer works across all continents and focuses on M&A and private placements after selling its Fondsfinans brokerage business in 2018.

(www.beringerfinance.com)

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorised and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.

(www.bryangarnier.com)


European Investment Bank Bryan, Garnier & Co names new Partner in ECM

PARIS, LONDON, MUNICH, NEW YORK: 20 February, 2019 – Bryan, Garnier & Co, a leading pan-European investment banking partnership focusing on growth companies, today announces that Pierre Kiecolt-Wahl is to become a Partner at the firm.

Pierre Kiecolt-Wahl, a dual American/French citizen joined Bryan, Garnier & Co’s European investment banking team as Managing Director, heading up the Equity Capital Markets division in May 2016. Pierre brings over 15 years of international equity capital markets knowledge with organizations such as Bank of America, Lehman Brothers, Jefferies and Citi, based in San Francisco, London and Hong Kong.

Since arriving at Bryan, Garnier & Co, he has led numerous transactions, continuing to strenghthen the firm’s footprint across Europe and the US. Key transactions include: Zealand Pharma Wall-Crossed Follow-On Offering (DKK 143m) | Symetis Euronext IPO & subsequent sale to Boston Scientific ($435m), Celyad Nasdaq & Euronext Publicly Marketed Follow-on Offering (€46m) | Ablynx Nasdaq IPO ($230m) | Medartis Six Swiss IPO (CHF 143m) | Canopy Growth Global Convertible Bond, Toronto Stock Exchange (CAD 600m) and Materialise’s Nasdaq Follow-on Offering ($45m).

Olivier Garnier, Co-founder & Managing Partner comments: “We are excited to welcome Pierre into the Bryan Garnier partnership, one of the few remaining independent investment banking partnerships in Europe. This makes us very special. Since founding the bank over 22 years ago, our business model has created a strong entrepreneurial culture that truly aligns us with the interest of our clients which Pierre has embraced. The personal commitment of our partners to the firm ensures a long-term perspective in building Bryan, Garnier & Co and our clients know they can count on us to stay the course with them as their business grows. We would like to congratulate Pierre for becoming Partner to Bryan, Garnier & Co. This is a very exciting time for the firm and we wish Pierre every success in his new role.”

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.

(www.bryangarnier.com)


Bryan, Garnier & Co strengthens its Healthcare team with the hiring of Jean-Jacques Le Fur as Senior Financial Analyst

PARIS, August 28, 2018 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Jean-Jacques Le Fur to its European Healthcare team.

With over 20 years of experience as a sell side analyst in European pharmaceuticals, Jean-Jacques will join the Healthcare team as an analyst and will help Bryan, Garnier & Co to leverage its footprint within the Healthcare sector.

Before joining Bryan, Garnier & Co, Jean-Jacques was a senior Pharmaceutical analyst at Oddo-BHF and Natixis. Before life as an analyst, he held various positions in R&D and Finance at Hoechst-Marion-Roussel and Ipsen.

Eric Le Berrigaud, Managing Partner in Paris comments: “I have known Jean-Jacques for many years and I am delighted to have him join us to take our already very successful healthcare practice to the next level.  The new team will have the objective of covering more companies across all segments, increasing the number of client events as well actively being involved in more transactions.”

Jean-Jacques Le Fur adds: “Bryan Garnier & Co is a leader in the Healthcare sector combining stock market and banking services with an entrepreneurial culture. I look forward to contributing to the continued development of the Healthcare team and transforming ideas into opportunities for our clients.”

Jean-Jacques holds a degree in Pharmacy (PharmD) from Paris University as well as an MBA, from IAE, Paris.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.

(www.bryangarnier.com)


Bryan, Garnier & Co strenghtens its Business Services team with the hiring of Marc Picard as Executive Advisor

PARIS, March 13, 2018 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Marc Picard to its European Business Services team.

With over 20 years of experience in global finance including 17 years in M&A, Marc will participate in the development of mid-market deals, in particular family-owned businesses, as well as help Bryan, Garnier & Co leverage its footprint within the business service sector. He will be based in Paris.

Before joining Bryan, Garnier & Co, Marc worked at HSBC France for five years and then joined Ernst & Young where he finally co-led the M&A team across various activities including: Distribution, Recycling, Facility Management, Building and Public works and Real Estate. During this time, Marc assisted numerous mid-market private companies in securing capital for growth.

Guillaume Nathan, Partner, Business Services Practice, Paris comments: "I am delighted to have Marc join Bryan, Garnier & Co to help us in developing our Business Services Practice. Thanks to his deep knowledge of the industry and close relationship with some key players, we are already engaged in some visible transactions".

Marc Picard adds: "Bryan, Garnier & Co is a high performing European financial services firm with an extensive access to the American market through his partnership with JMP. The combination of a fully integrated investment bank with a broad geographical presence and a deep specialization in Business Services give us a unique means to help our clients achieve ambitious goals. I am pleased to support the team in developing the Business Services line".

Marc holds a Master’s Degree in Political Sciences from Sciences Po Paris where he majored in Economics and Finance.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.

(www.bryangarnier.com)


Bryan, Garnier & Co strenghtens its Business Services franchise with the hiring of Stanislas de Gmeline as Managing Director

PARIS, December 19, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Stanislas de Gmeline to its European Business Services franchise.

With over 18 years of experience in global finance, Stanislas will be responsible for LBO origination, and help Bryan, Garnier & Co to reinforce its footprint within the Business Services sector. He will be based in Paris.

Before joining Bryan, Garnier & Co, Stanislas, spent 10 years in investment banking working for both bulge brackets banks (HSBC, Credit Suisse) and independent M&A boutiques in London and Paris, as well as 7 years in venture capital and small-cap LBO investment for private banks. He is also the Founder of Valbrenne Finance, an independent Corporate Finance advisory boutique dedicated to entrepreneurs and family offices.

Greg Revenu, Managing Partner, Bryan, Garnier & Co comments: “I am delighted to have Stanislas join our Business Services franchise. He brings with him not only a solid expertise in Investment Banking (M&A, ECM, Private Banking, Private Equity investment and Corporate Finance advisory) but also an entrepreneurial spirit – a perfect match for the Bryan, Garnier’s business ambitions and culture”.

Stanislas adds: “Bryan, Garnier & Co is a unique, truly European financial services firm combining the depth and breadth of fully-integrated investment banks with the flexibility of entrepreneurial partnerships, thus providing people with rare opportunities to help clients achieve ambitious targets. I really look forward to assisting its teams strengthen the firm’s footprint in the field of Business Services and with financial sponsors alike”.

Stanislas holds a Master of Business Administration from INSEAD as well as a Master’s Degree in Political Sciences from Sciences Po, in Paris where he majored in Economics and Finance.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.

(www.bryangarnier.com)


Bryan, Garnier & Co grows its TMT franchise with the hiring of Charlie Pujo as Director

PARIS, December 6 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Charlie Pujo to its Technology, Media & Telecoms team.

With over 10 years of experience in financial and strategic advisory services notably in M&A, Charlie, will be responsible for the development of the software and technology practice of Bryan, Garnier & Co. He will assist the TMT team in sourcing and executing ECM and M&A mandates for European growth tech companies, private equity funds and corporates. He will be based in Paris.

Prior to joining Bryan, Garnier & Co, Charlie worked as an investment banker for Société Générale, (London) in their TMT, Aerospace & Defense – M&A advisory services – where he was responsible for the development of the Technology and Aerospace & Defense franchise. Charlie has also previously held positions at Qwant.com where he was Strategic Advisor and Deputy CEO, Arma Partners and Lehman Brothers.

Olivier Beaudouin, Partner, Bryan, Garnier & Co, Paris comments: "I am delighted to have Charlie join the Technology, Media and Telecoms franchise, strengthening our capacity to continue to support fast growth companies in Europe".

Charlie adds: "I am thrilled to join Bryan, Garnier & Co, and I am looking forward to working with its first class tech corporate finance team which is renowned in the market for its deep sector knowledge and strong client commitment".

Charlie is a graduate from the Supaero/ISAE School of Aeronautics and Space where he obtained a Major in System Modelling and Financial Engineering.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.


Bryan, Garnier & Co hires leading expert in Deep Technologies

MUNICH, November 27, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Professor Dr. Hermann Eul as Senior Advisor to its Smart Industries practice, based in Paris and Munich. Hermann has over 15 years of Deep Technology experience across a range of fields including communication systems, high performance processors, and software intelligence.  Hermann will take on the role as Senior Advisor to the franchise across Europe.

Prior to joining Bryan, Garnier & Co, Hermann held senior executive positions at Siemens, Infineon, and Intel. At Siemens, he led business units in mobile infrastructure and semiconductors.  During a decade at Infineon, he held several roles including Head of security and chip card ICs, President of the Communication Solutions business, CTO, CMO, EVP, and was also a member of the management board.

During his five years at Intel, Hermann led a worldwide organization focused on hardware, software and connectivity for phones, tablets, Ultrabooks, and mobile devices. He was also Corporate VP, President of the worldwide Mobile & Communications Group, and President and Managing Director of Intel Germany.

Hermann currently holds board roles in numerous Deep Technology companies including the Knowles Corp (acoustic solutions, Itasca USA), Redpine Signals (low power Wifi modules, San Jose USA), Locata Corp (high precision positioning, Australia), and a number of Silicon Valley Start-ups.  In addition he has board roles at industry associations (VDE, Germany) and investment funds (Digital Plus Partners, Germany), as well as being an angel investor through the Band of Angels (San Francisco USA), and Sand Hill Angels (Los Altos USA).

Olivier Beaudouin, Partner, Bryan, Garnier & Co comments, “Emerging applications for autonomous and intelligent systems, such as machine vision, machine learning and AI require immense processing speed and power. Software is reaching the limits of its capabilities and is being complemented once again by a wave of innovation in high power high speed processors for specific applications. Hermann brings breadth of experience and a well-established network across relevant B2B markets, including microelectronics, materials, semiconductor / optical convergence, parallel and distributed processing. This will complement Bryan Garnier’s Deep Technology expertise and transactional experience in the space”.

Hermann adds: “I was impressed by Bryan Garnier’s track record of execution, reach and understanding in a confluence of industry spaces that are increasingly demanding higher performance, power and speed from optimized software and processors. I look forward to working with them to help growing companies realize their global ambitions”.

Hermann holds B.Sc., M.Sc., and Ph.D. degrees in Electrical, Electronic and Communications Engineering from Fachochschule, Koblenz, and Ruhr University, Bochum respectively, and held a full chair / professorship in RF Technology and Transmission Systems at Leibniz University Hannover.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.


Bryan, Garnier & Co hires Phil Walker as Managing Director in its London Healthcare division

LONDON, October, 30  2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is proud to announce the hiring of senior banker Phil Walker to join its European Healthcare division in London.

Phil Walker has advised on more than 60 successful transactions including IPOs, secondary fundraisings and M&A in the UK, Europe, Israel and the US. He joins Bryan, Garnier & Co as Managing Director UK Healthcare Corporate Finance.

Phil, British, is a corporate financier and equity capital markets investment banker with 20 years’ experience advising healthcare/life science and high growth technology companies.

Prior to joining Bryan, Garnier & Co, he was Head of Healthcare and Cleantech corporate finance at Zeus Capital Limited.  Previously, Phil was a Co-founder of investment banking boutique, Code Securities, which was acquired by Nomura. Prior to Code Securities, he spent five years as a specialist healthcare corporate financier in the WestLB Panmure Life Sciences Group, then Europe's leading healthcare investment bank. Phil qualified as a chartered accountant with Price Waterhouse in 1997.

Phil Walker comments, “I am delighted to have joined Bryan, Garnier & Co. The firm shares my focus and long-term commitment to the healthcare sector and I look forward to building Bryan Garnier’s UK healthcare business to strengthen further the firm’s leading position in continental Europe".

Olivier Garnier, Managing Partner, adds: “I am pleased to have Phil join us to help build our UK business. The quality and the depth of his experience within the UK healthcare community will be a great asset for the team.  Phil’s appointment comes after Dominic Wilson and Gary Waanders joined the firm in last month and aims to reinforce the Bryan, Garnier Healthcare franchise in London".

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.

(www.bryangarnier.com)


Bryan, Garnier & Co strengthens its Investment Banking team with the hiring of Marc-Antoine Janny as Vice President

PARIS, October 17, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome back Marc-Antoine Janny to its European investment banking team, based in Paris.

With over eight years of corporate finance  experience in M&A and ECM, Marc-Antoine, will join the firm as Vice President and will be responsible for the origination and execution of private placement and M&A mandates for European growth companies, as well as help Bryan, Garnier & Co to leverage its footprint within its healthcare and TMT practices.

Marc-Antoine worked for Bryan, Garnier & Co as an M&A analyst from 2008 to 2011 when he left to join Michel Dyens & Co. He then founded Canary Street, the first European marketplace dedicated to the distribution of emerging designers in the home decor environment whose assets were acquired by Belgium-based e-commerce company Decovry. In 2015 he joined goetzpartners before moving back to Bryan, Garnier & Co as a Vice President.  During his career, he has developed a significant experience in M&A, ECM and fundraising transactions including: Capital increase of Airlinair (subsidiary of Air France), IPO of Integragen, disposal of Vemedia to Industri Kapital, disposal of Russia-based Ekomir Pharma to Valeant and the disposal of Italy-based Sharper Therapeutics to Gruppo Indena della Beffa.

Greg Revenu, Managing Partner, Paris comments: “I am delighted to welcome Marc-Antoine back to the Bryan, Garnier & Co investment banking team.  Marc-Antoine has an entrepreneurial mindset having successfully founded, funded, run and sold a start-up and as such brings with him a valuable perspective to best support the founders we advise”.

Marc-Antoine adds: “I am pleased to be back at Bryan, Garnier & Co and have a particular attachment to the firm and the great people working here. I started my career at the company and truly believe in its market positioning, strong track record and deep sector expertise in TMT and Healthcare sectors making it ideal to serve growth companies in Europe. I am looking forward to contributing to its future growth in the European market”.

Marc-Antoine holds a master in Finance from Grenoble Graduate School of Business and Singapore Management University.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Media & Telecoms, Healthcare, Smart Industries & Energy, Consumer, Brands & Retail and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.

(www.bryangarnier.com)


Wilson and Waanders join London Healthcare franchise as Managing Directors

LONDON, September 26,  2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is proud to announce two new experienced hires to join its European Healthcare division in London.

Dominic Wilson and Gary Waanders have together conducted more than 15 transactions and raised over £370m since early 2014 working on numerous IPOs and secondary fund raisings. They join Bryan, Garnier & Co as Managing Directors and are tasked with leveraging their combined experience in the UK market to further strengthen the bank’s already formidable footprint in the sector across Europe.

Dominic Wilson, British, has a held a variety of positions in the healthcare sector during his long career.  He started his financial work as a Healthcare analyst based in New York, for Kleinwort Benson Securities and then moved on to hold numerous senior sales positions in the UK including Head of Sales at Old Mutual Securities, Piper Jaffray Ltd as Principal, European Equity Sales, Arden Partners and, more recently, Nomura Code as Head of Sales before joining Zeus in 2013 as Head of Healthcare Sales. Dominic has a BSc (Hons) in Genetics.

Gary Waanders, Australian, has a long experience of working in the life sciences and financial sectors. Since 2001 he has been an analyst in the City of London where he has previously worked as Director of Healthcare Research at Zeus Capital, Nomura Code Securities and KBC Peel Hunt. He has also worked in industry and academia including two years managing R&D teams at a small biotech company in Canada and six years as a Post-Doctoral Research fellow at the Ludwig Institute for Cancer Research (Lausanne Branch, Switzerland). He holds an MBA (Durham University, UK) and a PhD in Immunology from the Faculty of Medicine, Monash University, Melbourne (Australia).

Dominic Wilson and Gary Waanders comment, “We are delighted to join Bryan, Garnier & Co and to continue to work together. We have known and respected the firm for many years and regard it highly as the leading independent European investment bank specializing in growth companies, particularly in healthcare, a sector to which we and Bryan Garnier share a strong focus and commitment”.

Olivier Garnier, Managing Partner, comments: "I am pleased to welcome Dominic and Gary to our dedicated healthcare franchise, made up of over 20 senior professionals, to continue to build our business as the investment bank of choice for any European healthcare company. Our track record in M&A as well as growth financing built over 20 years of experience, is firmly established in the market.

We are also the most active independent investment bank involved in IPO‘s and follow-ons of European healthcare growth companies on Nasdaq, advising companies such as LDR, Celyad, DBV and Galapagos. Over the last three years, Bryan Garnier has completed over 14 transactions for European healthcare growth companies, raising a total of over $1 billion and including the sale of Symetis to Boston Scientific for $435 million last April".

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Media & Telecoms, Healthcare, Smart Industries & Energy, Consumer, Brands & Retail and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.

(www.bryangarnier.com)